CLINICAL-EVALUATION OF 5-HT3 RECEPTOR ANTAGONISTS AS ANTIEMETICS

被引：48
作者：
BUNCE, K
TYERS, M
BERANEK, P
机构：
[1] Glaxo Group Research Ltd, Ware
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 1991年 / 12卷 / 02期
关键词：
D O I：
10.1016/0165-6147(91)90493-C
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：46 / 48
页数：3
相关论文
共 30 条
[1]   THE ABDOMINAL VISCERAL INNERVATION AND THE EMETIC REFLEX - PATHWAYS, PHARMACOLOGY, AND PLASTICITY [J].
ANDREWS, PLR ;
DAVIS, CJ ;
BINGHAM, S ;
DAVIDSON, HIM ;
HAWTHORN, J ;
MASKELL, L .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1990, 68 (02) :325-345
[2]   PHARMACOLOGICAL PROPERTIES OF GR38032F, A NOVEL ANTAGONIST AT 5-HT3 RECEPTORS [J].
BUTLER, A ;
HILL, JM ;
IRELAND, SJ ;
JORDAN, CC ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (02) :397-412
[3]  
CARMICHAEL J, 1989, CANCER CHEMOTH PHARM, V24, P45
[4]   THE SEROTONIN TYPE-3 RECEPTOR ANTAGONIST BRL-43694 AND NAUSEA AND VOMITING INDUCED BY CISPLATIN [J].
CARMICHAEL, J ;
CANTWELL, BMJ ;
EDWARDS, CM ;
RAPEPORT, WG ;
HARRIS, AL .
BRITISH MEDICAL JOURNAL, 1988, 297 (6641) :110-111
[5]   PHARMACOKINETICS AND ANTI-EMETIC EFFICACY OF BRL43694, A NEW SELECTIVE 5HT-3 ANTAGONIST [J].
CASSIDY, J ;
RAINA, V ;
LEWIS, C ;
ADAMS, L ;
SOUKOP, M ;
RAPEPORT, WG ;
ZUSSMAN, BD ;
RANKIN, EM ;
KAYE, SB .
BRITISH JOURNAL OF CANCER, 1988, 58 (05) :651-653
[6]   EFFICACY OF ONDANSETRON (GR-38032F) AND THE ROLE OF SEROTONIN IN CISPLATIN-INDUCED NAUSEA AND VOMITING [J].
CUBEDDU, LX ;
HOFFMANN, IS ;
FUENMAYOR, NT ;
FINN, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (12) :810-816
[7]   PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST [J].
CUNNINGHAM, D ;
POPLE, A ;
FORD, HT ;
HAWTHORN, J ;
GAZET, JC ;
CHALLONER, T ;
COOMBES, RC .
LANCET, 1987, 1 (8548) :1461-1463
[8]  
CUNNINGHAM D, 1989, LANCET, V1, P1323
[9]   THE EFFICACY OF GR38032F, AN ANTAGONIST OF 5-HYDROXYTRYPTAMINE-3 (5-HT3) IN THE PROPHYLAXIS OF CISPLATIN (CDDP)-INDUCED NAUSEA AND VOMITING [J].
DEHAAN, LD ;
DEMULDER, PHM ;
BEEX, LVAM ;
DEBRUYNE, FMJ ;
CHALLONER, T ;
DEPAUW, BE .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (08) :1383-1384
[10]   A PHASE-I STUDY OF A NEW 5HT3-RECEPTOR ANTAGONIST, BRL43694A, AN AGENT FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING [J].
FALKSON, G ;
VANZYL, AJ .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 24 (03) :193-196
123